The British Society for Rheumatology and the National Rheumatoid Arthritis Society have released a joint statement expressing disappointment on the rejection of their appeal to the National Institute for Health and Care Excellence to allow the payment of biologic medications to treat moderate to severe rheumatoid arthritis, rather than only severe disease activity.
The statement can be read here.
Implementing the Care Act for people with fluctuating, long-term conditions
The National Rheumatoid Arthritis Society has worked with several other charities representing those with fluctuating LTCs to produce a briefing on the implications of the Care Act.
The statement can be read online here.